Screener
Bentley Pharmaceuticals BNT Q3 2026 earnings
Reported November 12, 2026 · Before market open
Revenue$3.6B
EPS$0.07
Next report
Feb 11, 2027 (in 3 months)Versus estimates
Revenue
Diluted EPS
FAQ
- When did Bentley Pharmaceuticals report Q3 2026 earnings?
- Bentley Pharmaceuticals (BNT) reported Q3 2026 earnings on November 12, 2026 before market open.
- What were Bentley Pharmaceuticals's Q3 2026 revenue and EPS?
- Bentley Pharmaceuticals reported revenue of $3.6B and eps of $0.07 for Q3 2026.
- How did Bentley Pharmaceuticals's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 15.3% from $3.1B a year earlier and eps grew 16.7% from $0.06.
